4 unknown, 3 completed, 1 active not recruiting, 1 recruiting. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Unknown 4, Completed 3, Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Genital Wart: new trials by email Literature Review of Genital Wart trials Research Report on Genital Wart
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha), Placebo - Genital Wart, Penile Cancer | Phase 3 | Active not recruiting | Shanghai Bovax Biotechnology Co., Ltd. | 9000 | 2024-07-11 | 2024-12-12 |
| A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha), Placebo - Cervical Cancer, Genital Wart | Phase 3 | Terminated | Shanghai Bovax Biotechnology Co., Ltd. | 3131 | 2022-12-09 | 2023-07-21 |
| Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 Zerun HPV-9, GARDASIL ®9 - Cervical Cancer, Genital Wart | Phase 3 | Unknown | Shanghai Zerun Biotechnology Co.,Ltd | 1200 | 2022-09-01 | 2022-10-28 |
| Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years 2-doses Group among 9-14 years, 3-doses Group among 9-19 years, 3-doses Group among 20-26 years - HPV Infections, Cervical Cancer Stage IIa | Phase 3 | Unknown | Shanghai Bovax Biotechnology Co., Ltd. | 1348 | 2021-09-15 | 2024-04-17 |
| Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years 9-valent HPV vaccine - HPV Infections, Cervical Cancer | Phase 3 | Unknown | Shanghai Bovax Biotechnology Co., Ltd. | 1200 | 2021-05-28 | 2024-04-17 |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58), Active Comparator: GARDASIL ®9 - HPV Infections, Cervical Cancer | Phase 3 | Completed | Shanghai Bovax Biotechnology Co., Ltd. | 1200 | 2020-09-19 | 2023-11-24 |
| Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females 4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL® - Cervical Cancer, Vulvar Cancer | Phase 3 | Completed | Shanghai Bovax Biotechnology Co., Ltd. | 1680 | 2020-05-28 | 2022-02-25 |
| Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha), GARDASIL® - Cervical Cancer, Vulvar Cancer | Phase 3 | Recruiting | Shanghai Bovax Biotechnology Co., Ltd. | 8000 | 2020-04-28 | 2024-06-07 |
| Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients tuberculin, cryotherapy - Genital Wart | Phase 3 | Unknown | Assiut University | 45 | 2017-06-01 | 2017-05-17 |
| Low Dose Cyclophosphamide Treats Genital Warts cyclophosphamide - Genital Wart | Phase 3 | Completed | Huazhong University of Science and Technology | 104 | 2007-01-01 | 2009-11-25 |
Condylomata Acuminata (10) · Uterine Cervical Neoplasms (7) · Vaginal Neoplasms (5) · Papillomavirus Infections (4) · Vulvar Neoplasms (4) · Anus Neoplasms (1) · Penile Neoplasms (1)
Communicable Diseases (10) · DNA Virus Infections (10) · Disease Attributes (10) · Genital Diseases (10) · Infections (10) · Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Sexually Transmitted Diseases (10) · Sexually Transmitted Diseases, Viral (10) · Skin Diseases (10) · Skin Diseases, Infectious (10) · Skin Diseases, Viral (10) · Skin and Connective Tissue Diseases (10) · Tumor Virus Infections (10) · Urogenital Diseases (10)
Vaccines, Synthetic (3) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (2) · Cryotherapy (1) · Cyclophosphamide (1) · Tuberculin (1)
Shanghai Bovax Biotechnology Co., Ltd. (7) · Assiut University (1) · Huazhong University of Science and Technology (1) · Shanghai Zerun Biotechnology Co.,Ltd (1)
China (9)
Bo Huang, PH.D, MD (1) · Lidong Gao, Master (1) · Long Sui, Doctor (1) · Ting Huang (1)
PMID 11238198, PMID 12807939, PMID 15897380, PMID 16973081, PMID 23336207, PMID 25273231